Rayca Precision
Pouya Behrouzi is the CEO and Co-Founder of Rayca Precision, a position held since August 2022, and also serves as Co-Founder of Eavono, which focuses on emulating human organs on a single disk through the integration of cell biology, artificial intelligence, and innovative engineering for drug discovery. Prior experience includes roles as a Research Collaborator at Tehran University of Medical Sciences and a Researcher at Bushehr University of Medical Sciences, where significant focus was placed on addressing human degenerative disorders through 3D bio-printing and stem cell biology. Additionally, Pouya Behrouzi held the position of R&D Director and Product Manager at Percia Vista Biotechnology Company, contributing to the development of advanced bioprinting systems. Earlier research experience includes a role as a Research Scholar at the TAVANA Nanotechnology Laboratory, which provided foundational knowledge and mentorship in nanotechnology.
This person is not in any teams
Rayca Precision
We’re aspiring towards a precise analysis of the molecular characteristics of a patient together with their specific tumor and cancer affliction in this instance. We are currently developing an AI based precision oncology platform that increases survival rate of cancer patients by providing oncologists with data driven decision making support.Rayca utilize high-throughput patient genomic data to identify the molecular pathways of cancer diseases to identify tumor behaviors in very early stages and assist clinical decision making.